Cross-sectional analysis shows elevated biomarker levels are linked to increased diabetic kidney disease risk, suggesting predictive potential.
Elevated RAR levels are significantly associated with increased risk of diabetic kidney disease among individuals with diabetes, suggesting its strong predictive potential. As a simple and cost-effective biomarker, RAR may serve as a useful tool for early DKD risk screening and stratification. However, prospective studies are warranted to further validate its clinical utility.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: